96 weeks of pegylated-Interferon- alpha-2? plus tenofovir or placebo for the treatment of hepatitis delta: the HIDIT-2 study

Basit Öğe Kaydı
dc.contributor.authorWedemeyer, Heiner
dc.contributor.authorYurdaydin, Cihan
dc.contributor.authorErnst, Stefanie
dc.contributor.authorCaruntu, Florin A.
dc.contributor.authorCurescu, Manuela G.
dc.contributor.authorYalcin, Kendal
dc.contributor.authorAkarca, Ulus S.
dc.date.accessioned2024-04-24T17:49:59Z
dc.date.available2024-04-24T17:49:59Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases -- NOV 01-05, 2013 -- Washington, DCen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.endpage223Aen_US
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.startpage222Aen_US
dc.identifier.urihttps://hdl.handle.net/11468/23135
dc.identifier.volume58en_US
dc.identifier.wosWOS:000330252201031
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofHepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.title96 weeks of pegylated-Interferon- alpha-2? plus tenofovir or placebo for the treatment of hepatitis delta: the HIDIT-2 studyen_US
dc.title96 weeks of pegylated-Interferon- alpha-2? plus tenofovir or placebo for the treatment of hepatitis delta: the HIDIT-2 study
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu